{"entity":{"id":"nct06586866","kind":"trial","name":"JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases","aka":[],"tldr":"A phase 2 trial in triple-negative breast cancer, run by JenKem Technology Co., Ltd., not yet recruiting.","summary":"JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases is a phase 2, interventional study registered as NCT06586866 by JenKem Technology Co., Ltd., with a registry enrolment figure of 25 participants, started 2024-09-26 and due to reach its primary completion in 2026-05-26. Interventions recorded: JK-1201I. Conditions listed: Triple Negative Breast Cancer (TNBC); Brain Metastasases. Triple-negative eligibility wording from the registry: \"Histological or cytological confirmation of triple-negative breast cancer (TNBC)\". No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06586866","url":"https://clinicaltrials.gov/study/NCT06586866"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-early","brain-metastases"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06586866","phase":"2","setting":"A Multicenter, Single-Arm, Phase 2 Study to Evaluate the Safety, Efficacy and Pharmacokinetics of JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases","sponsor":"JenKem Technology Co., Ltd.","enrolled":25,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06586866/","neighbours":{"cancer":[{"id":"tnbc-early","kind":"cancer","name":"Early triple-negative breast cancer","route":"/cancers/tnbc-early/"}],"term":[{"id":"brain-metastases","kind":"term","name":"Brain metastases (intracranial disease)","route":"/terms/brain-metastases/"},{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}